Revisión
Eficacia y seguridad de vedolizumab en el tratamiento de la colitis ulcerosa
Efficacy and safety of vedolizumab in the treatment of ulcerative colitis
a Servicio de Aparato Digestivo, Hospital Universitari Germans Trias i Pujol, Badalona, España
b Servicio de Aparato Digestivo, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), Madrid, España
c Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD)
Leído
33884
Vecesse ha leído el artículo
2194
Total PDF
31690
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 95 | 0 | 95 |
| 2025 11 | 398 | 61 | 459 |
| 2025 10 | 419 | 22 | 441 |
| 2025 9 | 367 | 26 | 393 |
| 2025 8 | 429 | 21 | 450 |
| 2025 7 | 405 | 21 | 426 |
| 2025 6 | 491 | 13 | 504 |
| 2025 5 | 441 | 14 | 455 |
| 2025 4 | 793 | 16 | 809 |
| 2025 3 | 434 | 15 | 449 |
| 2025 2 | 330 | 10 | 340 |
| 2025 1 | 413 | 27 | 440 |
| 2024 12 | 395 | 9 | 404 |
| 2024 11 | 485 | 24 | 509 |
| 2024 10 | 513 | 9 | 522 |
| 2024 9 | 444 | 26 | 470 |
| 2024 8 | 329 | 21 | 350 |
| 2024 7 | 336 | 15 | 351 |
| 2024 6 | 378 | 17 | 395 |
| 2024 5 | 368 | 15 | 383 |
| 2024 4 | 352 | 15 | 367 |
| 2024 3 | 461 | 20 | 481 |
| 2024 2 | 424 | 18 | 442 |
| 2024 1 | 472 | 17 | 489 |
| 2023 12 | 406 | 36 | 442 |
| 2023 11 | 554 | 32 | 586 |
| 2023 10 | 522 | 25 | 547 |
| 2023 9 | 330 | 18 | 348 |
| 2023 8 | 381 | 11 | 392 |
| 2023 7 | 373 | 13 | 386 |
| 2023 6 | 337 | 25 | 362 |
| 2023 5 | 470 | 23 | 493 |
| 2023 4 | 391 | 29 | 420 |
| 2023 3 | 344 | 16 | 360 |
| 2023 2 | 240 | 20 | 260 |
| 2022 1 | 197 | 23 | 220 |
| 2022 12 | 186 | 20 | 206 |
| 2022 11 | 270 | 26 | 296 |
| 2022 10 | 219 | 29 | 248 |
| 2022 9 | 322 | 31 | 353 |
| 2022 8 | 244 | 30 | 274 |
| 2022 7 | 247 | 27 | 274 |
| 2022 6 | 278 | 31 | 309 |
| 2022 5 | 252 | 22 | 274 |
| 2022 4 | 233 | 23 | 256 |
| 2022 3 | 347 | 37 | 384 |
| 2022 2 | 329 | 26 | 355 |
| 2021 1 | 359 | 26 | 385 |
| 2021 12 | 253 | 33 | 286 |
| 2021 11 | 310 | 47 | 357 |
| 2021 10 | 361 | 40 | 401 |
| 2021 9 | 362 | 35 | 397 |
| 2021 8 | 259 | 20 | 279 |
| 2021 7 | 265 | 45 | 310 |
| 2021 6 | 440 | 63 | 503 |
| 2021 5 | 626 | 22 | 648 |
| 2021 4 | 1080 | 55 | 1135 |
| 2021 3 | 654 | 38 | 692 |
| 2021 2 | 451 | 26 | 477 |
| 2020 1 | 452 | 48 | 500 |
| 2020 12 | 478 | 19 | 497 |
| 2020 11 | 477 | 34 | 511 |
| 2020 10 | 347 | 22 | 369 |
| 2020 9 | 383 | 25 | 408 |
| 2020 8 | 382 | 30 | 412 |
| 2020 7 | 340 | 27 | 367 |
| 2020 6 | 414 | 25 | 439 |
| 2020 5 | 357 | 42 | 399 |
| 2020 4 | 297 | 16 | 313 |
| 2020 3 | 435 | 28 | 463 |
| 2020 2 | 420 | 30 | 450 |
| 2020 1 | 528 | 27 | 555 |
| 2019 12 | 352 | 15 | 367 |
| 2019 11 | 414 | 34 | 448 |
| 2019 10 | 340 | 26 | 366 |
| 2019 9 | 490 | 39 | 529 |
| 2019 8 | 235 | 25 | 260 |
| 2019 7 | 325 | 31 | 356 |
| 2019 6 | 328 | 40 | 368 |
| 2019 5 | 374 | 49 | 423 |
| 2019 4 | 251 | 9 | 260 |
| 2019 3 | 89 | 22 | 111 |
| 2019 2 | 102 | 14 | 116 |
| 2019 1 | 67 | 11 | 78 |
| 2018 12 | 59 | 8 | 67 |
| 2018 10 | 3 | 6 | 9 |
| 2018 9 | 1 | 0 | 1 |
| 2018 7 | 0 | 1 | 1 |
| 2018 6 | 2 | 0 | 2 |
| 2018 5 | 2 | 0 | 2 |
| 2018 4 | 1 | 1 | 2 |
| 2018 2 | 3 | 0 | 3 |
| 2018 1 | 5 | 0 | 5 |
| 2017 12 | 3 | 0 | 3 |
| 2017 11 | 3 | 0 | 3 |
| 2017 10 | 3 | 0 | 3 |
| 2017 9 | 1 | 0 | 1 |
| 2017 8 | 0 | 1 | 1 |
| 2017 7 | 4 | 0 | 4 |
| 2017 6 | 2 | 0 | 2 |
| 2017 5 | 3 | 0 | 3 |
| 2017 4 | 2 | 0 | 2 |
| 2017 3 | 6 | 2 | 8 |
| 2017 2 | 6 | 1 | 7 |
| 2016 1 | 8 | 0 | 8 |
| 2016 12 | 27 | 4 | 31 |
| 2016 11 | 5 | 2 | 7 |
| 2016 10 | 0 | 1 | 1 |
| 2016 9 | 0 | 1 | 1 |
| 2016 8 | 0 | 1 | 1 |
| 2016 7 | 0 | 2 | 2 |
Mostrar todo
